0001567619-22-011345.txt : 20220519 0001567619-22-011345.hdr.sgml : 20220519 20220519203919 ACCESSION NUMBER: 0001567619-22-011345 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220517 FILED AS OF DATE: 20220519 DATE AS OF CHANGE: 20220519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hanna Betsy CENTRAL INDEX KEY: 0001885957 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 22945004 MAIL ADDRESS: STREET 1: C/O TREACE MEDICAL CONCEPTS, INC. STREET 2: 203 FORT WADE RD #150 CITY: PONTE VEDRA BEACH STATE: FL ZIP: 32081 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 471052611 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 203 FORT WADE ROAD STREET 2: SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 203 FORT WADE ROAD STREET 2: SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 4 1 doc1.xml FORM 4 X0306 4 2022-05-17 0 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001885957 Hanna Betsy C/O TREACE MEDICAL CONCEPTS, INC. 203 FORT WADE ROAD, SUITE 150 PONTE VEDRA FL 32081 1 0 0 0 Common Stock 2022-05-17 4 A 0 1187 0 A 1187 D Common Stock 2022-05-17 4 A 0 2295 0 A 3482 D Stock Option (Right to Buy) 15.80 2022-05-17 4 A 0 8600 0 A 2032-05-17 Common Stock 8600 8600 D Stock Option (Right to Buy) 15.80 2022-05-17 4 A 0 16625 0 A 2032-05-17 Common Stock 16625 16625 D Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will vest in three equal yearly installments starting May 17, 2023 such that the RSUs will be fully vested on May 17, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date. Represents RSUs for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on May 17, 2023 subject to Reporting Person's providing continued service to Issuer through the vesting date. The stock option vests over three years in substantially equal monthly installments with the first vesting to occur on June 17, 2022 such that the stock option will be fully vested and exercisable on May 17, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date. The stock option will vest in 12 substantially equal monthly installments, commencing on June 17, 2022, such that the stock option will be fully vested and exercisable on May 17, 2023, subject to Reporting Person's providing continued service to Issuer through each vesting date. /s/ Lisa Taylor as Attorney-in-fact for Betsy Hanna 2022-05-19